Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure

Gut

Volumn 50, Issue 1, 2002, Pages 111-117

  Anand, R ^a   Harry, D ^a   Holt, S ^a   Milner, P ^a   Dashwood, M ^a   Goodier, D ^b   Jarmulowicz, M ^b   Moore, K ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; GALACTOSAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HISTOPATHOLOGY; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER FAILURE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TISSUE DISTRIBUTION;

EID: 0036137009     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.50.1.111     Document Type: Article

References (44)

1. Renal failure of patients with cirrhosis of the liver. I. Clinical and pathological characteristics
2. Hepatorenal syndrome
3. Renal failure in fulminant hepatic failure and terminal cirrhosis: A comparison between incidence, types and prognosis
4. Frequency and type of renal and electrolyte disorders in fulminant hepatic failure
5. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
6. Renal function in fulminant hepatic failure: Haemodynamics and renal prostaglandins
7. Renal failure in the patient with cirrhosis. The role of active vasoconstriction
8. Renal blood flow in cirrhosis: Relation to systemic and portal haemodynamics and liver function
9. Mesangial cell, glomerular and renal vascular resistance response to endothelin in the rat kidney. Elucidation of signal transduction pathways
10. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
11. Endothelin: An important factor in acute renal failure
12. Endothelin induces an increase in renal vascular resistance and a fall in glomerular filtration rate in the rabbit isolated perfusion kidney
13. Effect of endothelin on renal function in rats
14. Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers
15. Detection of endothelin-1 mRNA by CT-PCR in isolated rat renal tubules
16. Production of endothelin-1 by rat cultured mesangial cells
17. Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands
18. Characterization of ET receptors in the inner medullary collecting duct of the rat
19. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome
20. Increased plasma endothelin levels in patients with liver cirrhosis
21. Elevated circulating plasma endothelin-1 concentrations in cirrhosis
22. Experimental hepatitis induced by D-galactosamine
23. Systemic and hepatic hemodynamic changes in acute liver injury
24. Hepatosplanchnic hemodynamics and renal blood flow and function in rats with liver failure
25. Pharrmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist
26. Cytokines suppress the shear stress-stimulated release of vasoactive peptides from human endothelial cells
27. 125I]endothelin binding sites in human blood vessels and coronary tissue: Functional correlates
28. [125I]-PD151242: A selective radioligand for human ETA receptors
29. Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala 1,3,11,15]ET-1 in human heart
30. Validation of miniature ultrasonic transit-time flow probes for measurement of renal blood flow in rats
31. Acute tubular necrosis in hepatorenal syndrome: An electron microscopy study
32. Protective effect of S-adenosyl-L-methionine on bromobenzene-and D-galactosamine-induced toxicity to isolated rat hepatocytes
33. Relationship of systemic and intrarenal haemodynamics in cirrhosis
34. Renal blood flow in obstructive jaundice: An experimental study in baboons
35. Mechanisms of altered renal perfusion in the early stage of obstructive jaundice
36. Effect of chronic bile duct obstruction on renal handling of salt and water
37. Importance of renal postaglandins in control of renal function after chronic ligation of the common bile duct in dogs
38. Renal perfusion in dogs with experimental hepatic cirrhosis: Role of prostaglandins
39. Mechanism of hepatorenal syndrome in rats of Long-Evans Cinnamon strain, an animal model of fulminant Wilson's disease
40. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites
41. Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation
42. Amelioration of hepatorenal syndrome with selective endothelin-A antagonist
43. Renal endothelin system in obstructive jaundice: Its role in impaired renal function of bile-duct ligated rats
44. Localization of endothelin-like immunoreactivity in rat kidneys